Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, PET, FVT

Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference


SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise Bevers, Co-Founder and Chief Operating Officer, will participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference, being held on October 11, 2017 in New York City. The event will feature one-on-one meetings at which investors will have the opportunity to meet with management to discuss key therapeutic programs in development and upcoming milestones.

Kindred Biosciences, Inc. Logo

About Kindred Biosciences 

Kindred Biosciences is a pre-commercialization stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

Contact

Russell Radefeld
KindredBio
[email protected] 
(650) 701-7904

 

SOURCE Kindred Biosciences, Inc.


These press releases may also interest you

at 18:55
Orion Group ("Orion"), a commercial and industrial field services company backed by Alpine Investors ("Alpine"), announced today that it has partnered with Academy Locksmith ("Academy"). Academy provides mechanical and electronic locksmithing, door,...

at 18:30
St. Joseph's Hospital today announced that it becomes the first health care facility to use checkout-free technology in a hospital cafeteria, demonstrating BayCare and St. Joseph's Hospital's commitment to innovation, patient care and team member...

at 18:06
OpenStax at Rice University was awarded $90 million from the U.S. National Science Foundation to build and lead SafeInsights, a groundbreaking research and development (R&D) hub for inclusive learning and education research to benefit tens of...

at 18:05
Motlow State Community College has expanded its commitment to accessibility for learners with the addition of the YuJa Panorama Digital Accessibility Platform, a high-impact digital accessibility solution for higher education. The institution is part...

at 18:00
Drone Delivery Canada Corp. or (the "Company" or "DDC") is pleased to announce its 2023 financial results, and to provide a general corporate update....

at 18:00
SEMIFIVE, a leading design solution provider and pioneer of platform-based custom silicon solutions, has announced a collaboration with MetisX to develop a Compute Express Link (CXL)-based memory accelerator chip. The aim of this collaboration is to...



News published on and distributed by: